Is Recursion Pharmaceuticals Inc halal to invest in?

According to Musaffa's Shariah screening methodology, Recursion Pharmaceuticals Inc (RXRX) is currently classified as NOT HALAL as of February 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Recursion Pharmaceuticals Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Recursion Pharmaceuticals Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Recursion Pharmaceuticals Inc?

Muslim investors may consider investing in Recursion Pharmaceuticals Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Recursion Pharmaceuticals Inc classified as NOT HALAL?

Musaffa determines the Shariah status of Recursion Pharmaceuticals Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Recursion Pharmaceuticals Inc updated?

The Shariah compliance status of Recursion Pharmaceuticals Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Recursion Pharmaceuticals Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Recursion Pharmaceuticals Inc?

You can check the latest Shariah compliance status of Recursion Pharmaceuticals Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

RXRX Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: February 27, 2026

Report Source: 2025 Annual Report

Recursion Pharmaceuticals Inc. Stock Analysis RXRX

United States Health Care Small Cap Report: 2025 Annual

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel medicines. The company is headquartered in Salt Lake City, Utah and currently employs 600 full-time employees. The company went IPO on 2021-04-16. Its Recursion Operating System (OS), a platform built across diverse technologies, enables the Company to map and navigate trillions of biological and chemical relationships within the Recursion Data Universe. The firm integrates physical and digital components as iterative loops of atoms and bits, scaling wet lab biology and chemistry data organized into virtuous cycles with computational tools to rapidly translate silico hypotheses into validated insights and novel chemistry. Its clinical programs in oncology and rare diseases include REC-617, REC-1245, REC-3565 and REC-4539. Its REC-617 is an orally bioavailable, cyclin-dependent kinase 7 (CDK7) inhibitor for the treatment of advanced solid tumors. Its REV102 program targets ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1), an enzyme implicated in the pathogenesis of HPP.

Key Statistics of Recursion Pharmaceuticals Inc (RXRX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$2.92$3.05

Today's Open

$3.00

Volume

17.43M

P/E Ratio (TTM)

52 Week Range

$2.80$7.18

Market Cap

1.78B

Avg. Volume

12.45M

Dividend Yield

Financial Metrics & Statements of Recursion Pharmaceuticals Inc (RXRX)

FAQ's for Recursion Pharmaceuticals Inc (RXRX)

According to Musaffa’s Shariah screening methodology, Recursion Pharmaceuticals Inc (RXRX) is currently classified as NOT HALAL as of February 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.